Cardiff Oncology (CRDF) Upgraded to Buy: Here's What You Should Know

• click to rate

  Posted by Two Blokes May 14 - Filed in Stock - 1 view
  
  Cardiff Oncology (CRDF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).